|
FAM114A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.152000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.358800E-04 |
| Normal-vs-Stage2 |
1.98691999999667E-05 |
| Normal-vs-Stage3 |
2.802200E-02 |
| Normal-vs-Stage4 |
1.029390E-01 |
| Stage1-vs-Stage2 |
1.133620E-01 |
| Stage1-vs-Stage3 |
3.003400E-01 |
| Stage1-vs-Stage4 |
4.238800E-01 |
| Stage2-vs-Stage3 |
2.600300E-02 |
| Stage2-vs-Stage4 |
7.009500E-02 |
| Stage3-vs-Stage4 |
9.473200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.696500E-03 |
| Normal-vs-AfricanAmerican |
1.686640E-01 |
| Normal-vs-Asian |
3.155900E-03 |
| Caucasian-vs-AfricanAmerican |
7.400800E-01 |
| Caucasian-vs-Asian |
3.359800E-01 |
| AfricanAmerican-vs-Asian |
3.436800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.970900E-04 |
| Normal-vs-Female |
5.190300E-04 |
| Male-vs-Female |
5.024800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.780100E-03 |
| Normal-vs-Age(41-60Yrs) |
4.401400E-04 |
| Normal-vs-Age(61-80Yrs) |
3.177000E-04 |
| Normal-vs-Age(81-100Yrs) |
2.253600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.882800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.159590E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.824200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.624800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.155000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.504400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.678600E-01 |
| Classical-VS-Follicular |
1.10169995348741E-09 |
| Classical-VS-Other |
1.321770E-01 |
| Classical-VS-Normal |
1.353870E-02 |
| Tall-VS-Follicular |
5.025600E-04 |
| Tall-VS-Other |
8.229700E-02 |
| Tall-VS-Normal |
6.638800E-01 |
| Follicular-VS-Other |
8.570000E-01 |
| Follicular-VS-Normal |
5.05400166161962E-11 |
| Other-VS-Normal |
5.739600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.01179999998114E-06 |
| Normal-vs-N1 |
5.775100E-03 |
| N0-vs-N1 |
4.071000E-01 |
|
|
